US 12391741
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof
granted A61KA61K38/00A61K45/06
Quick answer
US patent 12391741 (T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof) held by MiNK Therapeutics, Inc. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MiNK Therapeutics, Inc.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K45/06, A61P, A61P35/00